1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Mexico Pharmaceuticals and Healthcare Report Q4 2015

Mexico Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 112 pages

Includes 3 FREE quarterly updates

BMI View: Robust relations with the US will continue to result in the growth of Mexico's pharmaceutical
and healthcare markets in 2015. Mexico's work to expand its international reach along with its positive economic outlook posture it to act as an outperformer in Latin America. Governmental focus on costcontainment initiatives will result in a booming demand for generic medications, as Mexico maintains its status as one of the largest consumers of generic drugs worldwide.

Headline Expenditure Projections

- Pharmaceuticals: MXN173bn (USD13bn) in 2014 to MXN177bn (USD12bn) in 2015; +2.7% in local currency terms and -9.5% in US dollar terms. Forecast revised downwards from Q315 due to revised historical data.

Table Of Contents

Mexico Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2011-2019) 16
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 21
Prescription Drug Market Forecast 22
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 27
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 29
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2013-2019) 31
Key Risks To BMI's Forecast Scenario 32
Macroeconomic Forecasts 33
Economic Analysis 33
Table: GDP By Expenditure (Mexico 2012-2019) 37
Pharmaceuticals and Healthcare Risk/Reward Index 38
Americas Risk/Reward Index - Q4 2015 38
Mexico Risk/Reward Index 44
Rewards 44
Risks 44
Market Overview 46
Industry Trends And Developments 47
Epidemiology 47
Healthcare Sector 49
Table: Healthcare Resources (Mexico 2009-2014) 49
Table: Healthcare Personnel (Mexico 2009-2014) 49
Table: Healthcare Activity (Mexico 2009-2014) 50
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation 53
Research And Development 54
Clinical Trials 55
Regulatory Development 57
Regulatory Developments 57
Biologics And Biosimilars Guidelines 58
Intellectual Property Issues 58
Pricing Regime 60
Reimbursement Regime 62
Competitive Landscape 63
Research-Based Industry 63
Generic Drugmakers 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 66
Table: IMSS Financial Indicators, 2000-11 (MXNmn) 67
Company Profile 68
Bayer 68
Boehringer Ingelheim 71
Bristol-Myers Squibb 74
Eli Lilly 77
Genomma Labs 80
GlaxoSmithKline (GSK) 83
Merck KGaA 86
Novartis 89
Pfizer 92
Roche 95
Sanofi 98
Demographic Forecast 101
Demographic Outlook 101
Table: Population Headline Indicators (Mexico 1990-2025) 102
Table: Key Population Ratios (Mexico 1990-2025) 102
Table: Urban/Rural Population and Life Expectancy (Mexico 1990-2025) 103
Table: Population By Age Group (Mexico 1990-2025) 103
Table: Population By Age Group % (Mexico 1990-2025) 104
Glossary 106
Methodology 108
Pharmaceutical Expenditure Forecast Model 108
Healthcare Expenditure Forecast Model 108
Notes On Methodology 109
Risk/Reward Index Methodology 110
Index Overview 111
Table: Pharmaceutical Risk/Reward Index Indicators 111
Indicator Weightings 112

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.